PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVLS.L Regulatory News (VLS)

  • There is currently no data for VLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting and Open Offer

15 Dec 2021 11:36

RNS Number : 7619V
Velocys PLC
15 December 2021
 

Velocys plc

("Velocys" or the "Company")

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR JAPAN.

Results of General Meeting and Open Offer

Velocys plc (VLS.L), the sustainable fuels technology company, is pleased to announce that the resolutions set out in the circular published on 29 November 2021 and put to shareholders at the General Meeting held earlier today were duly passed by means of a poll. A summary of the voting results is set out at the end of this announcement.

The Company is also pleased to announce that in relation to the Open Offer, which closed for acceptances at 11.00 a.m. on 14 December 2021, it has received final valid applications, including Excess Entitlements, from Eligible Shareholders in respect of a total of 15,314,974 Open Offer Shares. This represents a take-up of approximately 61.07% of the maximum number of Open Offer Shares available.

Accordingly, the Company has raised total gross proceeds of approximately £26.2 million in aggregate (before expenses) through the Placing Offer and Open Offer. Application has been made for 327,814,974 New Ordinary Shares to be admitted to trading on AIM ("Admission"). Issue of the New Ordinary Shares remains conditional on Admission occurring. It is expected that Admission of the VCT Shares (56,796,020 New Ordinary Shares) will occur on 16 December 2021 and Admission of the General Placing Shares and Open Offer Shares (255,703,980 and 15,314,974 New Ordinary Shares respectively) will occur on 17 December 2021. Following Admission, the Company will have1,393,571,031 Ordinary Shares in issue.

The Company does not currently hold any shares in treasury. Therefore, the above figure of 1,393,571,031 Ordinary Shares may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

The proxy voting results of the resolutions are included below:

Resolution

FOR

AGAINST

TOTAL

WITHHELD*

 

No. of votes cast

%

No. of votes cast

%

No. of votes cast

No.

Resolution 1

To grant the directors authority to allot shares in the Company in the amounts set out in the notice of general meeting

515,421,856

99.56

2,288,878

0.44

517,710,734

588,291

Resolution 2

Conditionally on Resolution 1, to empower the directors to disapply pre-emption rights on the issue of shares in the Company in the amounts set out in the notice of general meeting

514,710,766

99.45

2,834,165

0.55

517,544,931

754,094

*A vote withheld is not a vote in law and counts neither "For" nor "Against" the relevant resolution.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 29 November 2021.

 

Enquiries:

Velocys

Henrik Wareborn, CEO

Andrew Morris, CFO

Lak Siriwardene, Director of Communications & Sustainability

+44 1865 800821

Panmure Gordon (UK) Limited (Nomad and Joint Broker)

Emma Earl (Corporate Finance)

John Prior (Corporate Finance)

Hugh Rich (Corporate Broking)

+44 20 7886 2500

Shore Capital Stockbrokers Limited (Joint Broker)

Henry Willcocks (Corporate Broking)

Toby Gibbs (Corporate Advisory)

James Thomas (Corporate Advisory)

Liam Zabludowicz (Corporate Advisory)

+44 20 7408 4090

Buchanan (Financial PR)

Helen Tarbet

Simon Compton

+44 20 7466 5000

Radnor Capital (Investor Relations)

Joshua Cryer

Iain Daly

+44 20 3897 1830

 

 

Notes to Editors

 

Velocys is an LSE-listed, international sustainable fuels technology company, traded on the AIM, providing clients with a technology solution to enable the production of negative Carbon Intensity synthetic, drop-in fuels from a variety of waste materials. SAF ('Sustainable Aviation Fuel') is the only commercially available, permanent alternative to fossil aviation fuels.

The technology is IP-protected in all major jurisdictions.

Two reference projects in the US and UK (Bayou Fuels and Altalto) are designed to accelerate the adoption and standardise the Velocys proprietary Fischer Tropsch (FT) technology with an integrated end to end solution, including renewable power and sequestration. Velocys is enabling commercial scale SAF production in response to the clean energy transition.

Velocys technology pathway is enabling the next generation of low carbon sustainable fuels with significant additional positive air quality impacts.

www.velocys.com

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBNDBDDQBD
Date   Source Headline
14th Mar 20237:00 amRNSAppointment of Financial Adviser
13th Mar 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSBusiness Update
25th Jan 202311:07 amRNSVelocys and Bechtel Agreement
6th Jan 20233:06 pmRNSBlock listing Interim Review
12th Dec 20227:01 amRNS£2.5m UK Government grant for new e-fuels project
12th Dec 20227:00 amRNS£27m UK Government grant for Altalto project
27th Oct 20227:00 amRNSVelocys Reference Project Improved Decarbonisation
21st Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSVelocys to participate in Barclays CEO Conference
1st Sep 20227:00 amRNSTotal Voting Rights
15th Aug 20227:00 amRNSUpdate on climate legislation
28th Jul 20227:00 amRNSAdditional Application for Block Admission
19th Jul 20227:00 amRNSDirector/PDMR Shareholding
5th Jul 20227:00 amRNSBlock listing Interim Review
1st Jul 20227:00 amRNSTotal Voting Rights
23rd Jun 20227:00 amRNSGrant of Share Option to Director
21st Jun 20223:01 pmRNSResults of Annual General Meeting
9th Jun 20227:00 amRNSAppointment of Chief Financial Officer
30th May 20227:00 amRNSMailing of 2021 annual report and AGM notice
23rd May 20224:31 pmRNSHolding(s) in Company
18th May 20224:35 pmRNSPrice Monitoring Extension
17th May 20227:00 amRNSFinal Results
13th May 20229:36 amRNSInvestor Presentation
29th Apr 20227:00 amRNSNotice of Results
19th Apr 20227:00 amRNSFurther business update
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:36 pmRNSPrice Monitoring Extension
4th Apr 20227:00 amRNSBusiness Update and Notice of Results
1st Apr 20223:26 pmRNSNotification of Major Holdings
1st Apr 20223:21 pmRNSNotification of Major Holdings
24th Mar 20227:00 amRNSSale and purchase option agreed for Altalto site
8th Mar 20224:40 pmRNSSecond Price Monitoring Extn
8th Mar 20224:35 pmRNSPrice Monitoring Extension
1st Mar 20221:08 pmRNSHolding(s) in Company
1st Mar 20221:04 pmRNSHolding(s) in Company
1st Mar 202212:25 pmRNSTotal Voting Rights
10th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
5th Jan 20224:30 pmRNSBlock listing Interim Review
23rd Dec 20217:00 amRNSHolding(s) in Company
22nd Dec 20217:00 amRNSHolding(s) in Company
20th Dec 202110:51 amRNSHolding(s) in Company
17th Dec 20218:02 amRNSExercise of Option over Altalto Project Site
17th Dec 20218:01 amRNSDirector/PDMR Dealings
15th Dec 202111:36 amRNSResults of General Meeting and Open Offer
26th Nov 20217:00 amRNSResult of Placing
25th Nov 20215:09 pmRNSProposed Placing and Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.